TG Therapeutics TGTX Return on equity

Return on equity at other companies

BiogenBIIB

4.8%-4.3pp

Rhythm Pharmaceuticals, Inc.RYTM

-285.8%-68.9pp

Mirum Pharmaceuticals, Inc.MIRM

-335.8%-377pp

Vor BiopharmaVOR

-125.4%+671pp

Ultragenyx PharmaceuticalRARE

-325.6%+36.9pp

Shattuck Labs, Inc.STTK

-61%-8.0pp

FAQ

What is TG Therapeutics's return on equity?

TG Therapeutics (TGTX) reported return on equity of 100.3% in Q2 2026.

How has TG Therapeutics's return on equity changed year-over-year?

TG Therapeutics's return on equity increased by 276.5% year-over-year, from 26.6% to 100.3%.

What is the long-term trend for TG Therapeutics's return on equity?

Over 3 years (2021 to 2025), TG Therapeutics's return on equity has grown at a 3.7% compound annual growth rate (CAGR), from -92% to 102.8%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.